SARS-CoV-2 Variant Detection

World Health Organization (WHO) has been monitoring and assessing the evolution of SARS-CoV-2 since January 2020, and the emergence of new strains in recent months has triggered the characterisation of SARS-CoV-2 variants.

Veredus Laboratories is continuously monitoring the global situation of COVID-19 pandemic and conducting extensive impact assessment of SARS-CoV-2 variants on VereCoV™ OneMix Detection Assay, VereRT™ COVID-19 PCR Assay, VereRT™ ZeroPrep™ COVID-19 PCR Assay and VereRT™ Duo COVID-19 PCR Assay. Based on continuous bioinformatics (in silico) analysis, we are confident that the detection capability of our assays remains effective covering the following variant strains.

For more information, please download the document attached.